River Renal

Chinook Therapeutics

This biopharmaceutical company develops precision medicines for patients with rare and severe chronic kidney diseases.

Purespring Therapeutics

This company develops gene therapies for patients with chronic renal diseases to preserve kidney function and treat conditions like IgA nephropathy.

Nionyx Bio

The company develops adeno-associated virus gene therapies for patients with genetic kidney diseases.

Trestle Biotherapeutics

This company develops implantable bioengineered kidney tissues to restore renal function for patients suffering from end-stage renal disease.

Estuary Biotherapeutics

This biotechnology company develops targeted genetic medicines for patients with serious kidney conditions, specifically autosomal dominant polycystic kidney disease.

Reneo Pharmaceuticals

The company develops therapies for patients with rare genetic mitochondrial diseases that cause deficits in cellular metabolism and energy production.

Calliditas therapeutics

This biopharmaceutical company develops and commercialises medicines for patients with rare renal and hepatic diseases.

Nephris

The company develops therapies for chronic kidney disease in diabetic patients.